18
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Phenylthiourea compounds for treating HIV infection

Pages 1051-1053 | Published online: 25 Feb 2005

References

  • ARCHER RH, DYKES C, GERONDELIS P et al: Mutants of human immunodeficiency virus Type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture. j Viral. (2000) 74(18):8390–8401.
  • BELL FW, CANTRELL AS, HOGBERG m - et al: Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure- activity relationship studies of PETT analogs. j Med. Chem. (1995) 38(25):4929–4936.
  • CANTRELL AS, ENGELHARDT P, HOGBERG M et al.: Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs. (1996) j Med. Chem. 39(20:4261–74.
  • CASADO JL, HERTOGS K, RUIZ L etal.: Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen. Aids (2000) 14(2):F1–
  • DE CLERCQ E: Novel compounds in preclinicailearly clinical development for the treatment of HIV infections. Rev Med. Viral. (2000) 10(4):255–277.
  • DE CLERCQ E: The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection. Antiviral Res. (1998) 38(3):153–79.
  • DEEKS SG: Nonnucleoside reverse transcriptase inhibitor resistance. j Acquit: Immune Defic. Syndr. (2001) 26\(Suppl. 1):S25–33.
  • MOYLE G: The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy. Drugs (2001) 61(1):19–26.
  • ROUSSEAU MN, VERGNE L, MONTESB et al. Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy. (2001) J. Acquit: Immune Defic. Syndr. 26(1):36–43.
  • UCKUN FM, CHELSTROM LM, TUEL-AHLGREN L et al: TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus. Antimicrob. Agents Chemother. (1998) 42(2):383–388.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.